138 related articles for article (PubMed ID: 34342378)
41. Validation of the Fracture Risk Evaluation Model (FREM) in predicting major osteoporotic fractures and hip fractures using administrative health data.
Skjødt MK; Möller S; Hyldig N; Clausen A; Bliddal M; Søndergaard J; Abrahamsen B; Rubin KH
Bone; 2021 Jun; 147():115934. PubMed ID: 33757901
[TBL] [Abstract][Full Text] [Related]
42. Oral Bisphosphonate use Reduces Cardiovascular Events in a Cohort of Danish Patients Referred for Bone Mineral Density.
Rodríguez AJ; Ernst MT; Nybo M; Prieto-Alhambra D; Ebeling PR; Hermann AP; Abrahamsen B
J Clin Endocrinol Metab; 2020 Oct; 105(10):. PubMed ID: 32717068
[TBL] [Abstract][Full Text] [Related]
43. Predicting risk of osteoporotic and hip fracture in the United Kingdom: prospective independent and external validation of QFractureScores.
Collins GS; Mallett S; Altman DG
BMJ; 2011 Jun; 342():d3651. PubMed ID: 21697214
[TBL] [Abstract][Full Text] [Related]
44. Osteoporotic fracture rate among women with at least 1 year of adherence to osteoporosis treatment.
Modi A; Tang J; Sen S; Díez-Pérez A
Curr Med Res Opin; 2015 Apr; 31(4):767-77. PubMed ID: 25708648
[TBL] [Abstract][Full Text] [Related]
45. Comparison of Risk of Osteoporotic Fracture in Denosumab vs Alendronate Treatment Within 3 Years of Initiation.
Pedersen AB; Heide-Jørgensen U; Sørensen HT; Prieto-Alhambra D; Ehrenstein V
JAMA Netw Open; 2019 Apr; 2(4):e192416. PubMed ID: 31002319
[TBL] [Abstract][Full Text] [Related]
46. A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures.
Davis S; Martyn-St James M; Sanderson J; Stevens J; Goka E; Rawdin A; Sadler S; Wong R; Campbell F; Stevenson M; Strong M; Selby P; Gittoes N
Health Technol Assess; 2016 Oct; 20(78):1-406. PubMed ID: 27801641
[TBL] [Abstract][Full Text] [Related]
47. Validation of fragility fractures in primary care electronic medical records: A population-based study.
Martinez-Laguna D; Soria-Castro A; Carbonell-Abella C; Orozco-López P; Estrada-Laza P; Nogues X; Díez-Perez A; Prieto-Alhambra D
Reumatol Clin (Engl Ed); 2019; 15(5):e1-e4. PubMed ID: 29195740
[TBL] [Abstract][Full Text] [Related]
48. Longitudinal change in clinical fracture incidence after initiation of bisphosphonates.
Abelson A; Ringe JD; Gold DT; Lange JL; Thomas T
Osteoporos Int; 2010 Jun; 21(6):1021-9. PubMed ID: 19722103
[TBL] [Abstract][Full Text] [Related]
49. The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications.
Skjødt MK; Ernst MT; Khalid S; Libanati C; Cooper C; Delmestri A; Rubin KH; Javaid MK; Martinez-Laguna D; Toth E; Prieto-Alhambra D; Abrahamsen B
Osteoporos Int; 2021 Oct; 32(10):1961-1971. PubMed ID: 33721032
[TBL] [Abstract][Full Text] [Related]
50. Osteoporosis and Fracture Risk among Older US Asian Adults.
Lo JC; Yang W; Park-Sigal JJ; Ott SM
Curr Osteoporos Rep; 2023 Oct; 21(5):592-608. PubMed ID: 37542683
[TBL] [Abstract][Full Text] [Related]
51. Performance of FRAX in Men With Prostate Cancer: A Registry-Based Cohort Study.
Ye C; Morin SN; Lix LM; McCloskey EV; Johansson H; Harvey NC; Kanis JA; Leslie WD
J Bone Miner Res; 2023 May; 38(5):659-664. PubMed ID: 36807916
[TBL] [Abstract][Full Text] [Related]
52. Oral bisphosphonate prescription and non-adherence at 12 months in patients with hip fractures treated in an acute geriatric unit.
Gamboa A; Duaso E; Marimón P; Sandiumenge M; Escalante E; Lumbreras C; Tarrida A
Osteoporos Int; 2018 Oct; 29(10):2309-2314. PubMed ID: 30076454
[TBL] [Abstract][Full Text] [Related]
53. Development and validation of common data model-based fracture prediction model using machine learning algorithm.
Kong SH; Kim S; Kim Y; Kim JH; Kim K; Shin CS
Osteoporos Int; 2023 Aug; 34(8):1437-1451. PubMed ID: 37195320
[TBL] [Abstract][Full Text] [Related]
54. Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture.
Berry SD; Samelson EJ; Pencina MJ; McLean RR; Cupples LA; Broe KE; Kiel DP
JAMA; 2013 Sep; 310(12):1256-62. PubMed ID: 24065012
[TBL] [Abstract][Full Text] [Related]
55. Rationale of the Spanish FRAX model in decision-making for predicting osteoporotic fractures: an update of FRIDEX cohort of Spanish women.
Azagra R; Zwart M; Encabo G; Aguyé A; Martin-Sánchez JC; Puchol-Ruiz N; Gabriel-Escoda P; Ortiz-Alinque S; Gené E; Iglesias M; Moriña D; Diaz-Herrera MA; Utzet M; Manresa JM;
BMC Musculoskelet Disord; 2016 Jun; 17():262. PubMed ID: 27317560
[TBL] [Abstract][Full Text] [Related]
56. Total Hip Bone Mineral Density as an Indicator of Fracture Risk in Bisphosphonate-Treated Patients in a Real-World Setting.
Banefelt J; Timoshanko J; Söreskog E; Ortsäter G; Moayyeri A; Åkesson KE; Spångéus A; Libanati C
J Bone Miner Res; 2022 Jan; 37(1):52-58. PubMed ID: 34585781
[TBL] [Abstract][Full Text] [Related]
57. Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.
Hawley S; Leal J; Delmestri A; Prieto-Alhambra D; Arden NK; Cooper C; Javaid MK; Judge A;
J Bone Miner Res; 2016 Nov; 31(11):2008-2015. PubMed ID: 27377877
[TBL] [Abstract][Full Text] [Related]
58. Oral Bisphosphonate Use and All-Cause Mortality in Patients With Moderate-Severe (Grade 3B-5D) Chronic Kidney Disease: A Population-Based Cohort Study.
Alarkawi D; Ali MS; Bliuc D; Pallares N; Tebe C; Elhussein L; Caskey FJ; Arden NK; Ben-Shlomo Y; Abrahamsen B; Diez-Perez A; Pascual J; Pérez-Sáez MJ; Center JR; Judge A; Cooper C; Javaid MK; Prieto-Alhambra D
J Bone Miner Res; 2020 May; 35(5):894-900. PubMed ID: 31968134
[TBL] [Abstract][Full Text] [Related]
59. The clinician's guide to prevention and treatment of osteoporosis.
LeBoff MS; Greenspan SL; Insogna KL; Lewiecki EM; Saag KG; Singer AJ; Siris ES
Osteoporos Int; 2022 Oct; 33(10):2049-2102. PubMed ID: 35478046
[TBL] [Abstract][Full Text] [Related]
60. Validation of FRAX and the impact of self-reported falls among elderly in a general population: the HUNT study, Norway.
Hoff M; Meyer HE; Skurtveit S; Langhammer A; Søgaard AJ; Syversen U; Dhainaut A; Skovlund E; Abrahamsen B; Schei B
Osteoporos Int; 2017 Oct; 28(10):2935-2944. PubMed ID: 28668994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
